Collegium Pharmaceutical, Inc. COLL Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $74.95M+19.2% | $62.87M+7.6% | $58.44M+61.1% | $36.27M-17.4% | $43.89M-36.6% | ||
| $3.55M-15.0% | $4.18M-2.7% | $4.3M+2.1% | $4.21M+4.5% | $4.03M+4.5% | ||
| $41.26M-1.5% | $41.91M+5.4% | $39.75M+6.7% | $37.26M+2.2% | $36.45M+12.5% | ||
| $331.04M+0.5% | $329.32M+13.2% | $290.92M+36.9% | $212.48M+2.4% | $207.44M-3.1% | ||
| $1.21M-30.3% | $1.74M+7.3% | $1.62M-3.3% | $1.68M-10.9% | $1.88M+13.9% | ||
| -$52.23M+17.8% | -$63.53M-15.0% | -$55.23M+79.8% | -$273.32M+2.1% | -$279.31M+2.9% | ||
| $626.66M-1.4% | $635.56M+884% | $64.58M+33.3% | $48.44M-38.0% | $78.13M-27.5% | ||
| -$106.35M+3.5% | -$110.25M+15.0% | -$129.7M— | —— | —— | ||
| $172.46M+10.9% | $155.55M— | —— | —— | —— | ||
| $329.83M+0.7% | $327.58M+13.2% | $289.3M+37.1% | $211.05M+2.5% | $205.8M-3.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Collegium Pharmaceutical, Inc. generate?
- Collegium Pharmaceutical, Inc. (COLL) generated $331.0M in operating cash flow over the trailing twelve months.
- What is Collegium Pharmaceutical, Inc.'s free cash flow?
- After $1.2M of capital expenditures, Collegium Pharmaceutical, Inc.'s free cash flow was $329.8M over the trailing twelve months, up 60.3% year over year.
- Where does Collegium Pharmaceutical, Inc.'s cash flow data come from?
- Every line is extracted from Collegium Pharmaceutical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
